openPR Logo
Press release

Global Biosimilar Market by Classes (Insulin, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte- Colony Stimulating Factor (G-CSF), Monoclonal Antibody (mAb) and Interferon (IFN) & Markets (Developed & Emerging)- Industry Outlook 2020 Share, T

05-16-2017 10:42 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: WISE GUY RESEARCH CONSULTANTS PVT LTD

/ PR Agency: WISE GUY RESEARCH CONSULTANTS PVT LTD
Biosimilar

Biosimilar

Biosimilar

Get Sample Report @
https://www.wiseguyreports.com/sample-request/918127-global-biosimilar-market-by-industry-outlook-2020

Covered In This Report:

With much-awaited approval of biosimilar interchangeability by FDA, the dynamics in the much nascent US biosimilars market is about to change with long-lasting price competition. The report “Global Biosimilar Market by Classes (Insulin, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte- Colony Stimulating Factor (G-CSF), Monoclonal Antibody (mAb) and Interferon (IFN) & Markets (Developed & Emerging)- Industry Outlook 2020” provides an in-depth analysis of global biosimilars market focusing on key segments detailing approved and upcoming biosimilar products. Market outlook for aforementioned biosimilar classes has been provided for the period 2017-20.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities at the global and regional level. The report has been segmented as following:-

Market Segmentation by Classes
• Insulin
• Erythropoietin (EPO)
• Human Growth Hormone (HGH)
• Granulocyte- Colony Stimulating Factor (G-CSF)
• Monoclonal Antibody (mAb)
• Interferon (IFN)
Market Segmentation by Geography
• Developed Markets – Europe and the US
• Emerging Markets – China & India
Key Vendors
• Sandoz
• Hospira
• TEVA
• Celltrion
• Biocad
• Dong-A Pharmaceutical Co., Ltd.
• Stada

Make An Enquiry Before Buying This Report@ .
https://www.wiseguyreports.com/enquiry/918127-global-biosimilar-market-by-industry-outlook-2020

Table of Contents

1. Executive Summary
2. Research Methodology
3. Introduction
4. Global Biologics Market
4.1 OVERVIEW
4.1.1 Classification of Biologics
4.2 GLOBAL BIOLOGICS MARKET ANALYSIS
1.1.1 Market Sizing (Actual & Forecasted)
5. Global Biosimilars Market
5.1 OVERVIEW
5.2 MARKET ANALYSIS
5.2.1 Market Sizing (Actual & Forecasted)
2.1.1 Market Share by Region (Actual & Forecasted)
3.1.1 Market Share by Application (Actual & Forecasted)
4.1.1 Market by Product Pipeline
6. Global Biosimilars Market Segmentation
6.1 ERYTHROPOIETIN (EPO)
6.1.1 Overview
6.1.2 Market Analysis
6.2 INSULIN
6.2.1 Overview
6.2.2 Market Analysis
6.3 HUMAN GROWTH HORMONE (HGH)
6.3.1 Overview
6.3.2 Market Analysis
6.4 GRANULOCYTE- COLONY STIMULATING FACTOR (G-CSF)
6.4.1 Overview
6.4.2 6.4.2 Market Analysis
6.4.2 6.4.2 Market Analysis
6.5 MONOCLONAL ANTIBODY (MAB)
6.5.1 Overview
6.5.2 Market Analysis
6.6 INTERFERON (IFN)
6.6.1 6.6.1 Overview
6.6.2 Market Analysis
7. Global Biosimilars Market Analysis – Developed & Emerging Nations
7.1 DEVELOPED MARKET
7.1.1Europe
7.1.2 The US
7.2 EMERGING MARKET
7.2.1 China
7.2.2India
8. Global Biosimilars – Pricing Analysis
9. Global Biosimilar Industry – SWOT Analysis
10. Global Biosimilars Market Attractiveness Index
11. Global Biosimilars Market Dynamics
11.1 INDUSTRY TRENDS & DEVELOPMENTS
11.1.1 New Biosimilars Dominated by Large Globals
11.1.2 11.1.2 Biosimilar Interchangeability Guidance by FDA
11.1.3 11.1.3 Focus on Pharmerging Markets
11.2 GROWTH DRIVERS
11.2.1 11.2.1 Biological Patent Expiries
11.2.2 11.2.2 Cost saving
11.2.3 11.2.3 Increased use for Treatment of Chronic Diseases
11.3 CHALLENGES
11.3.1 11.3.1 High Cost of Development
11.3.2 11.3.2 Regulatory Uncertainty
11.3.3 11.3.3 Lower Adoption Rate of Biosimilars
11.3.4 11.3.4 Manufacturer Skills Gap
12. Competitive Landscape
12.1 MARKET SHARE BY COMPETITORS
12.2 MARKET SHARE BY DRUGS
13. Company Profiles
13.1 SANDOZ
13.2 HOSPIRA
13.3 TEVA
13.4 CELLTRION
13.5 BIOCAD
13.6 DONG-A PHARMACEUTICAL CO., LTD
13.7 STADA

Continued...
Buy Now @
https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=918127

Contact Us:
Norah Trent
Partner Relations & Marketing Manager
Sales@Wiseguyreports.Com
Ph: +1-646-845-9349 (Us)
Ph: +44 208 133 9349 (Uk)

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

WISE GUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune - 411028
Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Biosimilar Market by Classes (Insulin, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte- Colony Stimulating Factor (G-CSF), Monoclonal Antibody (mAb) and Interferon (IFN) & Markets (Developed & Emerging)- Industry Outlook 2020 Share, T here

News-ID: 537213 • Views:

More Releases from WISE GUY RESEARCH CONSULTANTS PVT LTD

Global LIMS Industry Analysis 2020 Market Growth, Trends, Opportunities And Forecast To 2026
Global LIMS Industry Analysis 2020 Market Growth, Trends, Opportunities And Fore …
LIMS Market 2020-2026 New Study Reports “LIMS Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports. Report Summary:- The Global LIMS Market Report 2020-2026 (Forecast Period) Offers An In-Depth Study Of Market Growth Factors, Future Evaluation, Country-Level Analysis, LIMS Market Distribution, And Competitive Landscape Study Of Significant Industry Players. Every Segment Of The Global LIMS Market Is Extensively Assessed In The
Asthma Drugs Market 2020 Global Industry Sales, Supply, Demand, Consumption, Analysis And Forecasts To 2026
Asthma Drugs Market 2020 Global Industry Sales, Supply, Demand, Consumption, Ana …
Asthma Drugs Market 2020-2026 New Study Reports “Asthma Drugs Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports. Report Summary:- The Global Asthma Drugs Market Report 2020-2026 (Forecast Period) Offers An In-Depth Study Of Market Growth Factors, Future Evaluation, Country-Level Analysis, Asthma Drugs Market Distribution, And Competitive Landscape Study Of Significant Industry Players. Every Segment Of The Global Asthma Drugs Market Is Extensively Assessed In The Research
Virtual Reality in Education 2020 Global Market Key Players - Alchemy VR, Avantis Education, EON Reality, Google, Oculus VR, Virtalis - Analysis And Forecast To 2026
Virtual Reality in Education 2020 Global Market Key Players - Alchemy VR, Avanti …
Virtual Reality in Education Market 2020-2026 New Study Reports “Virtual Reality in Education Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports. Report Summary:- The Global Virtual Reality in Education Market Report 2020-2026 (Forecast Period) Offers An In-Depth Study Of Market Growth Factors, Future Evaluation, Country-Level Analysis, Virtual Reality in Education Market Distribution, And Competitive Landscape Study Of Significant Industry Players. Every Segment Of The Global
Online Jewelry 2020 Global Market Key Players - Cartier, Tiffany & Co, Pandora, Chaumet, Tanishq, Van cleef & arpels-Analysis And Forecast To 2026
Online Jewelry 2020 Global Market Key Players - Cartier, Tiffany & Co, Pandora, …
Online Jewelry Market 2020-2026 New Study Reports “Online Jewelry Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports. Report Summary:- The Global Online Jewelry Market Report 2020-2026 (Forecast Period) Offers An In-Depth Study Of Market Growth Factors, Future Evaluation, Country-Level Analysis, Online Jewelry Market Distribution, And Competitive Landscape Study Of Significant Industry Players. Every Segment Of The Global Online Jewelry Market Is Extensively Assessed In The Research

All 5 Releases


More Releases for Biosimilar

Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Biosimilar Market Treating More for Less: The Booming Infliximab Biosimilar Mark …
Infliximab Biosimilar Market worth $ XX Million by 2030 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Infliximab Biosimilar Market- by Application (Crohn's Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis and Others), End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Direct Distribution Channels), Trends, Industry Competition Analysis, Revenue and Forecast To 2030." Get
Biosimilar Monoclonal Antibodies Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Biosimilar Monoclonal Antibodies Market by Product (infliximab, trastuzumab, rituximab, adalimumab, bevacizumab, cetuximab, ranibizumab, denosumab, eculizumab, and other pipeline products), Indication (oncology, inflammatory & autoimmune disorders, chronic diseases, blood disorders, and other indications), Clinical Trial/Pipeline Analysis, Future Trends, Industry Competition Analysis, Revenue and Forecast To 2031." The Biosimilar Monoclonal Antibodies Market Size is valued at 5.02
Infliximab Biosimilar Insight, 2023 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2023" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Interested to know more about the functioning of
Infliximab Biosimilar Insight, 2022 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2022" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Interested to know more about the functioning of